DDX41 and acute myeloid leukemia: Based on published studies of DDX41 carriers, approximately 1.5% to 3.8% of unselected MDS/AML patients carry a germline DDX41 variant (12, 43, 44), indicating that variants in this gene carry a high pre-test probability for a germline origin.